组织纤溶酶原激活剂 Tissue plasminogen activator英语短句 例句大全

组织纤溶酶原激活剂,Tissue plasminogen activator

1)Tissue plasminogen activator组织纤溶酶原激活剂

2)tissue-type plasminogen activator组织纤溶酶原激活剂

1.Erythrina trypsin inhibitor (ETI) is a natural serine protease inhibitor, with high inhibitive activity to trypsin, chemotrypsin andtissue-type plasminogen activator (t-PA).刺桐胰蛋白酶抑制剂(ETI)是一种丝氨酸蛋白酶抑制剂,可抑制胰蛋白酶、胰凝乳蛋白酶及组织纤溶酶原激活剂(t-PA)等。

3)tissue-type plasminogen activator组织型纤溶酶原激活剂

1.Expression of humantissue-type plasminogen activator in cow mammary gland;人组织型纤溶酶原激活剂牛乳腺生物反应器的研究

2.Studies on thrombolysis of recombinant humantissue-type plasminogen activator(rht-PA)and its mutants;重组人组织型纤溶酶原激活剂及其突变体的溶血栓研究

3.Trichoderma reesei 306 was a recombinant strain that can producetissue-type plasminogen activator(t-PA).里氏木霉(Trichoderma reesei)306是能够生物合成组织型纤溶酶原激活剂(t-PA)的基因工程菌株。

英文短句/例句

parison of Recombinant Tissue Plasminogen Activator, Urokinase and Defibrase in Vitro Simulation of Thrombolytic Test重组织型纤溶酶原激活剂、尿激酶和降纤酶体外溶栓效果比较

2.Evaluation of the therapeutic effect of thrombolytic therapy with rt-PA and nursing intervention in patients with acute myocardial infarction急性心肌梗死重组组织型纤溶酶原激活剂溶栓治疗的观察及护理

3.Therapeutic effect observation of thrombolysis with rt-PA intravenous in recurrent cerebral infarction重组组织型纤溶酶原激活剂对再发性脑梗死静脉溶栓治疗评价

4.Therapeutic Effect of Ultra Earlier Thrombolysis of Recombinant Tissue Plasminogen Activator in Acute Cerebral Infarction重组组织型纤溶酶原激活剂超早期溶栓治疗急性脑梗死的疗效

5.Thrombolytic therapy with intravenous recombinant tissue plasminogen activator for acute cerebral infarction重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死19例

6.The Recombinant Human Tissue-type Plasminogen Activator in the Treatment of Deep Venous Thrombosis of the Lower Extremities重组组织型纤溶酶原激活剂治疗下肢深静脉血栓形成的临床应用

7.Experimental study on prevention of the peritoneal adhesion by recombinant tissue-type plasminogen activator on rats重组组织型纤溶酶原激活剂预防大鼠腹腔粘连的实验研究

8.Therapeutic effect evaluation of recombinant tissue plasminogen activator in hyper acute cerebral infarction重组组织型纤溶酶原激活剂治疗急性脑梗死的疗效评价

9.Construction of Tissue-type Plasminogen Activator Variants and Their Expression in Prokaryotic and Eukaryotic Cells;组织型纤溶酶原激活剂（t-PA）突变体的构建及其表达研究

10.Construction of Eukaryotic Expessing Vector of Tissue Plasminogen Activator (t-PA);组织型纤溶酶原激活剂（t-PA）真核表达载体的构建

11.Advances in the Study of Tissue-type Plasminogen Activator and Its Toxicity in the Central Nervous System;组织型纤溶酶原激活剂与中枢神经系统毒性的研究进展

12.Construction of Tissue Plasminogen Activator-annexin A5 Fusion Gene组织型纤溶酶原激活剂—膜联蛋白A5融合基因的构建

parative study on intravenous rt-PA and uroninase thrombolytic strategy for acute myocardial infarction重组组织型纤溶酶原激活剂与尿激酶静脉内溶栓治疗急性心肌梗死的比较研究

14.Therapeutic effects of thrombolysis with rt-PA intravenous in patients with ultra-acute vertebrobasilar artery infarction重组组织型纤溶酶原激活剂超早期静脉溶栓治疗急性椎-基底动脉梗死的疗效观察

15.Intravenous thrombolysis with rt-PA on patients with acute cerebral infarction under the guide of multimodal magnetic resonance imaging多模式磁共振指导下重组组织型纤溶酶原激活剂静脉溶栓治疗急性脑梗死

16.Therapeutic Efficacy of rt-PA Combined with Edaravone on Acute Cerebral Infarction重组组织型纤溶酶原激活剂联合依达拉奉治疗急性脑梗死疗效观察

17.Studies of the Function and Mechanism of tPA on Sciatic Nerve Regeneration and Functional Recovery after Injury;组织型纤溶酶原激活剂（tPA）在坐骨神经损伤与恢复过程中的作用研究

18.Clinical Study of the Expression of Tissue Factor and Urokinase Plasminogen Activator Receptor in Breast Cancer组织因子、尿激酶型纤溶酶原激活剂受体在乳腺癌中的表达

相关短句/例句

tissue-type plasminogen activator组织纤溶酶原激活剂

1.Erythrina trypsin inhibitor (ETI) is a natural serine protease inhibitor, with high inhibitive activity to trypsin, chemotrypsin andtissue-type plasminogen activator (t-PA).刺桐胰蛋白酶抑制剂(ETI)是一种丝氨酸蛋白酶抑制剂,可抑制胰蛋白酶、胰凝乳蛋白酶及组织纤溶酶原激活剂(t-PA)等。

3)tissue-type plasminogen activator组织型纤溶酶原激活剂

1.Expression of humantissue-type plasminogen activator in cow mammary gland;人组织型纤溶酶原激活剂牛乳腺生物反应器的研究

2.Studies on thrombolysis of recombinant humantissue-type plasminogen activator(rht-PA)and its mutants;重组人组织型纤溶酶原激活剂及其突变体的溶血栓研究

3.Trichoderma reesei 306 was a recombinant strain that can producetissue-type plasminogen activator(t-PA).里氏木霉(Trichoderma reesei)306是能够生物合成组织型纤溶酶原激活剂(t-PA)的基因工程菌株。

4)tPA组织型纤溶酶原激活剂

1.Expression oftPAcDNA Gene in BHK 21 Cell;组织型纤溶酶原激活剂cDNA在BHK21细胞中的表达

2.The Expression oftPA Directed by the Bovine BLG Regulatory Elements in the Mammary Gland of Transgenic Mice;牛β-乳球蛋白基因调控序列指导组织型纤溶酶原激活剂在小鼠乳腺中的表达

3.From the point of view of large-scale and rapid purification oftPA, a variety of methods for the purification oftPA and the separation of single-chain and two-chaintPA were reviewed.简述了用于大规模生产组织型纤溶酶原激活剂(tPA)的重组动物细胞及其培养工艺。

5)tissue plasminogen activator组织型纤溶酶原激活剂

1.Construction oftissue plasminogen activator eukaryotic expression vector and its expression in MCF-7 cell line;组织型纤溶酶原激活剂真核表达载体的构建及其在乳癌细胞系MCF-7中的瞬时表达

2.Construction of humantissue plasminogen activator minigene;人组织型纤溶酶原激活剂突变体微小基因的构建

3.Changes and its clinical significance of serum brain-derived neurotrophic factor level and plasmatissue plasminogen activator level in patients with amnestic mild cognitive impairment;遗忘型轻度认知功能损害患者血清脑源性神经营养因子及血浆组织型纤溶酶原激活剂水平变化及其临床意义

6)Reteplase(rPA)组织纤维溶酶原激活剂

1.Reteplase(rPA) is a recombinant non-glycosylated form of human tissue plasminogen activator(tPA) in which the molecule has been genetically engineered to contain 357 of the 527 amino acids of the original protein.从人的黑素瘤细胞提取总RNA,进行RT-PCR,克隆了组织纤维溶酶原激活剂(tPA)基因,对其缺失突变,进一步克隆了溶栓药物瑞替普酶-reteplase(rPA)基因;以羊的β-乳球蛋白基因(BLG)作为调控序列,构建了瑞替普酶的乳腺表达载体BrPA。

延伸阅读

组织纤溶酶原激活剂分子式：CAS号：性质：又称组织型纤维蛋白溶酶原激活剂。天然物为单链分子，含527个氨基酸组成的糖蛋白。受纤溶酶或胰蛋白酶催化水解Arg275～Ile276肽后转变为由单二硫键相连的双链，其氨基端为重链(A链)，羧基端为轻链(B链)。轻链与胰蛋白酶等丝氨酸蛋白酶有很高的同源性，含有t-PA的活性中心His322，Asp371，Ser478。t-PA存在于人体很多组织和体液中溶解血纤维蛋白的丝氨酸蛋白(水解)酶。可选择性地高效激活血栓中纤溶酶原成为纤溶酶，后者水解血栓中的纤维蛋白。目前主要从人黑素瘤细胞培养物中提取t-PA，产品有单链和双链，分子量前者为67 000～68 000，后者两链分别为30 000和40 000。t-PA基因工程和蛋白质工程的目标是生产高效的药用t-PA产品。药用t-PA能高效地预防和治疗急性心肌梗塞等血栓性疾病。